Cargando…

Asthma exacerbations: Origin, effect, and prevention

Asthma is the most common chronic respiratory disease, affecting up to 10% of adults and 30% of children in the Western world. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity on patients and constitute a major burden on health care resou...

Descripción completa

Detalles Bibliográficos
Autores principales: Jackson, David J., Sykes, Annemarie, Mallia, Patrick, Johnston, Sebastian L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172902/
https://www.ncbi.nlm.nih.gov/pubmed/22133317
http://dx.doi.org/10.1016/j.jaci.2011.10.024
_version_ 1783524348568535040
author Jackson, David J.
Sykes, Annemarie
Mallia, Patrick
Johnston, Sebastian L.
author_facet Jackson, David J.
Sykes, Annemarie
Mallia, Patrick
Johnston, Sebastian L.
author_sort Jackson, David J.
collection PubMed
description Asthma is the most common chronic respiratory disease, affecting up to 10% of adults and 30% of children in the Western world. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity on patients and constitute a major burden on health care resources. Respiratory tract viruses have emerged as the most frequent triggers for exacerbations in both children and adults; however, the mechanisms underlying these remain poorly understood. More recently, it has become increasingly clear that interactions might exist between viruses and other triggers, increasing the likelihood of an exacerbation. In this article we begin with an overview of the health, economic, and social burden that exacerbations of asthma carry with them. This is followed by a review of the pathogenesis of asthma exacerbations, highlighting the various triggers responsible and multiple interactions that exist between them. The final section first addresses what preventative measures are currently available for asthma exacerbations and subsequently examines which of the new treatments in development might lessen the burden of exacerbations in the future.
format Online
Article
Text
id pubmed-7172902
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc.
record_format MEDLINE/PubMed
spelling pubmed-71729022020-04-22 Asthma exacerbations: Origin, effect, and prevention Jackson, David J. Sykes, Annemarie Mallia, Patrick Johnston, Sebastian L. J Allergy Clin Immunol Reviews and Feature Article Asthma is the most common chronic respiratory disease, affecting up to 10% of adults and 30% of children in the Western world. Despite advances in asthma management, acute exacerbations continue to occur and impose considerable morbidity on patients and constitute a major burden on health care resources. Respiratory tract viruses have emerged as the most frequent triggers for exacerbations in both children and adults; however, the mechanisms underlying these remain poorly understood. More recently, it has become increasingly clear that interactions might exist between viruses and other triggers, increasing the likelihood of an exacerbation. In this article we begin with an overview of the health, economic, and social burden that exacerbations of asthma carry with them. This is followed by a review of the pathogenesis of asthma exacerbations, highlighting the various triggers responsible and multiple interactions that exist between them. The final section first addresses what preventative measures are currently available for asthma exacerbations and subsequently examines which of the new treatments in development might lessen the burden of exacerbations in the future. American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. 2011-12 2011-11-28 /pmc/articles/PMC7172902/ /pubmed/22133317 http://dx.doi.org/10.1016/j.jaci.2011.10.024 Text en Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Reviews and Feature Article
Jackson, David J.
Sykes, Annemarie
Mallia, Patrick
Johnston, Sebastian L.
Asthma exacerbations: Origin, effect, and prevention
title Asthma exacerbations: Origin, effect, and prevention
title_full Asthma exacerbations: Origin, effect, and prevention
title_fullStr Asthma exacerbations: Origin, effect, and prevention
title_full_unstemmed Asthma exacerbations: Origin, effect, and prevention
title_short Asthma exacerbations: Origin, effect, and prevention
title_sort asthma exacerbations: origin, effect, and prevention
topic Reviews and Feature Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172902/
https://www.ncbi.nlm.nih.gov/pubmed/22133317
http://dx.doi.org/10.1016/j.jaci.2011.10.024
work_keys_str_mv AT jacksondavidj asthmaexacerbationsorigineffectandprevention
AT sykesannemarie asthmaexacerbationsorigineffectandprevention
AT malliapatrick asthmaexacerbationsorigineffectandprevention
AT johnstonsebastianl asthmaexacerbationsorigineffectandprevention